Phenotypic Spectrum in Individuals With Pathogenic <i>GABRG2</i> Loss- and Gain-of-Function VariantsAlessandra Rossi, Renzo Guerrini, Alberto Danieli et al.|Neurology|2025Cited by 10
Epilepsy, electroclinical features, and long‐term outcomes in Pitt–Hopkins syndrome due to pathogenic variants in the <i>TCF4</i> geneSara Matricardi, Alberto Verrotti, Paolo Bonanni et al.|European Journal of Neurology|2021Cited by 9
Is highly purified cannabidiol a treatment opportunity for drug‐resistant epilepsy in subjects with typical Rett syndrome and <scp>CDKL5</scp> deficiency disorder?Aglaia Vignoli, Nicola Specchio, Giulia Prato et al.|Epilepsia Open|2025Cited by 5
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Andrea Maialetti, Cristina Politi et al.|Neurology and Therapy|2025Cited by 1